John Maraganore, the former CEO of Alnylam Pharmaceuticals, launched City Therapeutics, a new startup with $135 million from ...

Local health institutions tried to address the needs of this new population, which had lacked basic public health care such as immunization and often didn’t understand the U.S. health system.

The MM+M Awards is celebrating its 21st year of recognizing healthcare marketing and media that is the most creative and ...

As the battle over Pfizer’s future continues, former executives said they would no longer support activist investor Starboard ...

Members of the House and Senate have proposed legislation 'to prohibit the distribution and sale of contaminated poppy seeds in order to prevent harm, addiction, and further deaths from ...

Like clothing, body types can go in and out of fashion — but this might be the first time a person’s figure is trending due to the rise of certain prescription drugs. Since GLP-1s like Ozempic and ...

Most employers have little idea what the pharmacy benefit managers they hire do with the money they exchange for the ...

As the immersive gaming platform scales its advertising and ecommerce offerings, Campaign explores how brands can best ...

Syneos Health, a 2024 MM+M Agency 100 honoree, appointed Costa Panagos as CEO. Syneos Health also announced two new ...

The lawsuit follows a ProPublica investigation that revealed that the heart transplant team at Newark Beth Israel let ...

Recent research suggests that the FDA’s black box warning for antidepressants may have had the opposite effect it intended.

Costa Panagos will join Syneos Health’s board of directors and succeed Colin Shannon as CEO, effective immediately.